Corvus Pharmaceuticals, Inc. - CRVS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 15, 2026 | — | P | A | 21,700.0 | 11.5316 | 250,235.72 | 21,700.0 | View | |
| Jun 15, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 15, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 15, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| Jun 15, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 15,000.0 | View | |
| May 20, 2026 | President and CEO | P | A | 1,932.0 | 12.01 | 23,203.32 | 1,195,035.0 | View | |
| May 20, 2026 | President and CEO | P | A | 5,000.0 | 12.05 | 60,250.0 | 1,193,103.0 | View | |
| Apr 27, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View |